ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool
Fusion Antibodies at ELRIG Drug Discovery 2026
Oct 14–15, 2026 London, UK ~3k attendees Website
Fusion Antibodies takes part in 1 session at ELRIG Drug Discovery 2026 in London, and exhibits at Booth J27. Its program centres on designing antibodies from scratch for the GLP-1 receptor. It compares structure-based zero-shot design with large language model driven library screening by mammalian display.
| Organization | ELRIG Drug Discovery 2026 Attendance |
|---|---|
Fusion Antibodies Belfast, UK | |
Antibody discovery, engineering and preclinical development partner for therapeutic and diagnostic antibodies in human and animal health. | Booth Exhibiting at Booth J27 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 12:25pm–12:40pm De Novo Antibody Design for GLP-1R: Structure-Based Zero-Shot vs. LLM-Driven Library Screening by Mammalian Display Comparing two AI approaches to designing antibodies against the GLP-1 receptor, one computed from structure and one screened from a large generated library. |
Instantly find 20 buyers from Fusion Antibodies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by ELRIG. Submit a correction